Amniotics – Company introduction
Meet and get the opportunity to ask questions directly to Amniotics CEO Kåre Engkilde.
Amniotics is a pre-clinical Biopharmaceutical company with focus on Stem-cell therapy. The company is located in Lund – Sweden.
They have an interesting pipeline, technology platform and own production (GMP), so they hold the full value-chain inhouse.
The company was listed on Nasdaq First North July the 6th. 2021 and current marketcap is 206 MSEK.